Related Experiment Video
Updated: Aug 5, 2026
Tissue-simulating Phantoms for Assessing Potential Near-infrared Fluorescence Imaging Applications in Breast Cancer Surgery
Published on: September 19, 2014
Prospective comparison of near-infrared I and II fluorescence imaging for intraoperative navigation in pediatric
Yu Tian1, Xinghai Chen2, Mao Ye2
1Department of Pediatric Surgery, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China; Faculty of Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, 999078, Macau Special Administrative Region of China; Department of Pediatric Surgery, Capital Institute of Pediatrics-Peking University Teaching Hospital, Beijing, China.
Background:
Complete resection is critical for cure in hepatoblastoma (HB), but small, superficial, or deep lesions may be missed by conventional intraoperative assessment or near-infrared window I (NIR-I) fluorescence imaging. We prospectively evaluated the feasibility and comparative performance of indocyanine green (ICG)-based near-infrared window II (NIR-II) fluorescence imaging during pediatric hepatoblastoma resection.
Methods:
Fourteen children with HB were prospectively enrolled. All patients received preoperative ICG administration and underwent intraoperative paired NIR-I and NIR-II fluorescence imaging using a self-developed multispectral imaging system. In vivo and ex vivo fluorescence findings were correlated with histopathology. In vivo tumor-to-normal ratio (TNR), ex vivo tumor-to-background ratio (TBR), and lesion detection performance were compared between the two modalities.
Results:
NIR-II imaging showed higher intraoperative TNR than NIR-I imaging (10.11 ± 3.48 vs 6.49 ± 3.48, P < 0.05) and higher ex vivo TBR (16.05 ± 8.43 vs 9.88 ± 5.35, P < 0.05). In specimen-based analysis, NIR-II showed higher sensitivity (88.9% vs 77.8%) and accuracy (84.4% vs 80.0%) than NIR-I imaging. NIR-II also identified additional satellite or metastatic lesions not clearly visualized by NIR-I imaging in representative cases and improved localization of deeply located tumors.
Conclusion:
ICG-based NIR-II fluorescence imaging is feasible in pediatric HB surgery and may provide incremental intraoperative visualization compared with NIR-I imaging, particularly for selected small, deep, or weakly fluorescent lesions. These preliminary findings support the complementary role of NIR-II imaging in intraoperative decision-making but require validation in larger studies with standardized follow-up.
Level Of Evidence:
Level III.
